1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hyperparathyroidism, Secondary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrikopoulos, NK; Antonopoulou, S; Demopoulos, CA; Iatrou, C; Moutafis, S; Movstakas, G; Tsoufakis, G; Ziroyannis, P | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
The influence of parathyroid hormone on platelet-activating factor (PAF) blood levels in hemodialysis patients.
Topics: Adult; Aged; Calcium; Hemorrhage; Humans; Hyperparathyroidism, Secondary; In Vitro Techniques; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Platelet Activating Factor; Platelet Aggregation; Renal Dialysis | 1995 |